Cyclacel raises $1.29M through registered direct and private placements of stock and warrants

Bio Green Med Solution, Inc.

Gross proceeds ~$1.29M from sale of 388,200 shares/pre-funded warrants at $3.315/share to institutional investors.
Issues unregistered warrants to purchase 388,200 shares at $3.19 each, exercisable for 7 years.
Insiders (CEO and CFO) purchase 7,956 shares and warrants on same terms in concurrent private placement.
Ladenburg Thalmann acts as placement agent; fees 8% of gross proceeds plus warrants.
Closing expected December 26, 2023; proceeds for working capital and general corporate purposes.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Bio Green Med Solution, Inc. entered into Securities Purchase Agreement with certain institutional investors ("Purchasers") valued at approximately $1.29 million (effective 2023-12-21).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional investors ("Purchasers")
Value: approximately $1.29 million
Effective: 2023-12-21

Exact text from the filing

On December 21, 2023, Cyclacel Pharmaceuticals, Inc. (the "Company," "we" or "us") entered into a securities purchase agreement ("Securities Purchase Agreement") with certain institutional investors ("Purchasers").

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.85

Bio Green Med Solution, Inc. entered into Securities Purchase Agreement with certain of our executive officers (effective 2023-12-21).

Action: entry
Agreement: equity purchase
Counterparty: certain of our executive officers
Effective: 2023-12-21

Exact text from the filing

On December 21, 2023, in a separate concurrent insider private placement (the "Insider Private Placement"), we also entered into a Securities Purchase Agreement with certain of our executive officers (the "Insider Securities Purchase Agreement")

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Bio Green Med Solution, Inc. entered into Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. (the "Placement Agent") (effective 2023-12-21).

Action: entry
Agreement: underwriting
Counterparty: Ladenburg Thalmann & Co. Inc. (the "Placement Agent")
Effective: 2023-12-21

Exact text from the filing

Ladenburg Thalmann & Co. Inc. (the "Placement Agent") acted as the exclusive placement agent for the Offerings, pursuant to a placement agency agreement (the "Placement Agency Agreement"), dated December 21, 2023, by and between the Company and the Placement Agent.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Bio Green Med Solution, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-129018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.